Diagnosis of neuronal ceroid lipofuscinosis: Mutation detection strategies

Expert Opinion on Medical Diagnostics

Volumn 1, Issue 3, 2007, Pages 351-362

  Getty, Amanda L ^a   Rothberg, Paul G ^a   Pearce, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

batten disease; neuronal ceroid lipofuscinosis

Indexed keywords

EID: 80052134089     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.1.3.351     Document Type: Review

References (111)

1. GOEBEL HH: The neuronal ceroid-lipofuscinoses. J. Child Neurol. ( 1995 ) 10 (6): 424-437
2. KOHLSCHUTTER A, GARDINER RM, GOEBEL HH: Human forms of neuronal ceroid-lipofuscinosis (Batten disease): consensus on diagnostic criteria, Hamburg 1992. J. Inherit. Metab. Dis. ( 1993 ) 16 (2): 241-244 (Pubitemid 23213638)
3. GOEBEL HH, MOLE S, LAKE BD: The neuronal ceroid lipofuscinoses (Batten disease). IOS Press, Amsterdam, The Netherlands ( 1999
4. TEIXEIRA C, GUIMARAES A, BESSA C et al. : Clinicopathological and molecular characterization of neuronal ceroid lipofuscinosis in the Portuguese population. J. Neurol. ( 2003 ) 250 (6): 661-667 (Pubitemid 36718351)
5. ELLEDER M, FRANC J, KRAUS J et al. : Neuronal ceroid lipofuscinosis in the Czech Republic: analysis of 57 cases. Report of the 'Prague NCL group'. Eur. J. Paediatr. Neurol. ( 1997 ) 1 (4): 109-114 (Pubitemid 127703433)
6. SIINTOLA E, LEHESJOKI AE, MOLE SE: Molecular genetics of the NCLs - status and perspectives. Biochim. Biophys. Acta ( 2006 ) 1762 (10): 857-864 (Pubitemid 44740124)
7. WILLIAMS RE, ABERG L, AUTTI T et al. : Diagnosis of the neuronal ceroid lipofuscinoses: an update. Biochim. Biophys. Acta ( 2006 ) 1762 (10): 865-872 (Pubitemid 44740125)
8. COLLINS J, HOLDER GE, HERBERT H, ADAMS GG: Batten disease: features to facilitate early diagnosis. Br. J. Ophthalmol. ( 2006 ) 90 (9): 1119-1124 (Pubitemid 44351141)
9. LEMAN AR, POLOCHOCK S, MOLE SE, PEARCE DA, ROTHBERG PG: Homogeneous PCR nucleobase quenching assays to detect four mutations that cause neuronal ceroid lipofuscinosis: T75P and R151X in CLN1, and IVS5-1G C and R208X in CLN2. J. Neurosci. Methods ( 2006 ) 157 (1): 124-131 (Pubitemid 44308363)
10. CABRERA-SALAZAR MA, ROSKELLEY EM, BU J et al. : Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile Batten disease. Mol. Ther. ( 2007 ) 15 (10): 1782-1788 (Pubitemid 47434184)
11. WEIMER JM, KRISCENSKI-PERRY E, ELSHATORY Y, PEARCE DA: The neuronal ceroid lipofuscinoses: mutations in different proteins result in similar disease. Neuromolecular Med. ( 2002 ) 1 (2): 111-124 (Pubitemid 37012520)
12. HALTIA M: The neuronal ceroid-lipofuscinoses: from past to present. Biochim. Biophys. Acta ( 2006 ) 1762 (10): 850-856 (Pubitemid 44740121)
13. MOLE SE, WILLIAMS RE, GOEBEL HH: Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics ( 2005 ) 6 (3): 107-126 (Pubitemid 41396987)
14. SIINTOLA E, PARTANEN S, STROMME P et al. : Cathepsin D defi ciency underlies congenital human neuronal ceroid-lipofuscinosis. Brain ( 2006 ) 129 (Part 6): 1438-1445 (Pubitemid 43999376)
15. STEINFELD R, REINHARDT K, SCHREIBER K et al. : Cathepsin D defi ciency is associated with a human neurodegenerative disorder. Am. J. Hum. Genet. ( 2006 ) 78 (6): 988-998 (Pubitemid 43787690)
16. MITCHISON HM, HOFMANN SL, BECERRA CH et al. : Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum. Mol. Genet. ( 1998 ) 7 (2): 291-297 (Pubitemid 28048545)
17. VESA J, HELLSTEN E, VERKRUYSE LA et al. : Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature ( 1995 ) 376 (6541): 584-587
18. HOFMANN SL, DAS AK, LU JY, SOYOMBO AA: Positional candidate gene cloning of CLN1. Adv. Genet. ( 2001 ) 45 : 69-92 (Pubitemid 33804468)
19. SHARP JD, WHEELER RB, LAKE BD et al. : Loci for classical and a variant late infantile neuronal ceroid lipofuscinosis map to chromosomes 11p15 and 15q21-23. Hum. Mol. Genet. ( 1997 ) 6 (4): 591-595 (Pubitemid 27142110)
20. SLEAT DE, DONNELLY RJ, LACKLAND H et al. : Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science ( 1997 ) 277 (5333): 1802-1805 (Pubitemid 27449188)
21. CONSORTIUM BD: Isolation of a novel gene underlying Batten disease, CLN3. The international Batten disease consortium. Cell ( 1995 ) 82 (6): 949-957
22. MUNROE PB, MITCHISON HM, O'RAWE AM et al. : Spectrum of mutations in the Batten disease gene, CLN3. Am. J. Hum. Genet. ( 1997 ) 61 (2): 310-316 (Pubitemid 27382306)
23. SAVUKOSKI M, KLOCKARS T, HOLMBERG V et al. : CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Nat. Genet. ( 1998 ) 19 (3): 286-288 (Pubitemid 28309345)
24. KLOCKARS T, SAVUKOSKI M, ISOSOMPPI J, PELTONEN L: Positional cloning of the CLN5 gene defective in the Finnish variant of the LINCL. Mol. Genet. Metab. ( 1999 ) 66 (4): 324-328 (Pubitemid 29390194)
25. WHEELER RB, SHARP JD, SCHULTZ RA et al. : The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. Am. J. Hum. Genet. ( 2002 ) 70 (2): 537-542 (Pubitemid 34112306)
26. GAO H, BOUSTANY RM, ESPINOLA JA et al. : Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am. J. Hum. Genet. ( 2002 ) 70 (2): 324-335 (Pubitemid 34112288)
27. SHARP JD, WHEELER RB, PARKER KA et al. : Spectrum of CLN6 mutations in variant late infantile neuronal ceroid lipofuscinosis. Hum. Mutat. ( 2003 ) 22 (1): 35-42 (Pubitemid 36807770)
28. WHEELER RB, SHARP JD, MITCHELL WA et al. : A new locus for variant late infantile neuronal ceroid lipofuscinosis-CLN7. Mol. Genet. Metab. ( 1999 ) 66 (4): 337-338 (Pubitemid 29390197)
29. SIINTOLA E, TOPCU M, AULA N et al. : The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. Am. J. Hum. Genet. ( 2007 ) 81 (1): 136-146 (Pubitemid 47001163)
30. RANTA S, ZHANG Y, ROSS B et al. : The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat. Genet. ( 1999 ) 23 (2): 233-236 (Pubitemid 29455400)
31. VINES DJ, WARBURTON MJ: Classical late infantile neuronal ceroid lipofuscinosis fi broblasts are defi cient in lysosomal tripeptidyl peptidase I. FEBS Lett. ( 1999 ) 443 (2): 131-135 (Pubitemid 29078617)
32. KWON JM, ROTHBERG PG, LEMAN AR et al. : Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype. Neurosci. Lett. ( 2005 ) 387 (2): 111-114 (Pubitemid 41134208)
33. MOLE SE: The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol. ( 2004 ) 14 (1): 70-76 (Pubitemid 38200592)
34. NORMAN RW, WOOD N: Congenital form of amaurotic family idiocy. J. Neur. Psychiat. ( 1941 ) 4 : 175-190
35. SALONEN T, JARVELA I, PELTONEN L, JALANKO A: Detection of eight novel palmitoyl protein thioesterase (PPT) mutations underlying infantile neuronal ceroid lipofuscinosis (INCL;CLN1). Hum. Mutat. ( 2000 ) 15 (3): 273-279 (Pubitemid 30132162)
36. HOFMANN SL, DAS AK, YI W, LU JY, WISNIEWSKI KE: Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase defi ciency. Mol. Genet. Metab. ( 1999 ) 66 (4): 234-239 (Pubitemid 29390179)
37. VOZNYI YV, KEULEMANS JL, MANCINI GM et al. : A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variants. J. Med. Genet. ( 1999 ) 36 (6): 471-474 (Pubitemid 29267747)
38. VANHANEN SL, PURANEN J, AUTTI T et al. : Neuroradiological fi ndings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease. Neuropediatrics ( 2004 ) 35 (1): 27-35 (Pubitemid 38332508)
39. WELEBER RG: The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses. Eye ( 1998 ) 12 (Part 3b): 580-590 (Pubitemid 28356668)
40. LUKACS Z, SANTAVUORI P, KEIL A, STEINFELD R, KOHLSCHUTTER A: Rapid and simple assay for the determination of tripeptidyl peptidase and palmitoyl protein thioesterase activities in dried blood spots. Clin. Chem. ( 2003 ) 49 (3): 509-511 (Pubitemid 36250218)
41. VAN DIGGELEN OP, KEULEMANS JL, WINCHESTER B et al. : A rapid fl uorogenic palmitoyl-protein thioesterase assay: pre- and postnatal diagnosis of INCL. Mol. Genet. Metab. ( 1999 ) 66 (4): 240-244 (Pubitemid 29390180)
42. VAN DIGGELEN OP, KEULEMANS JL, KLEIJER WJ et al. : Pre- and postnatal enzyme analysis for infantile, late infantile and adult neuronal ceroid lipofuscinosis (CLN1 and CLN2). Eur. J. Paediatr. Neurol. ( 2001 ) 5 (Suppl. A): 189-192 (Pubitemid 32677137)
43. DE VRIES BB, KLEIJER WJ, KEULEMANS JL et al. : First-trimester diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) using PPT enzyme assay and CLN1 mutation analysis. Prenat. Diagn. ( 1999 ) 19 (6): 559-562 (Pubitemid 29271822)
44. SLEAT DE, GIN RM, SOHAR I et al. : Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am. J. Hum. Genet. ( 1999 ) 64 (6): 1511-1523 (Pubitemid 30481504)
45. HAINES JL, BOUSTANY RM, ALROY J et al. : Chromosomal localization of two genes underlying late-infantile neuronal ceroid lipofuscinosis. Neurogenetics ( 1998 ) 1 (3): 217-222 (Pubitemid 128684244)
46. DAS AK, LU JY, HOFMANN SL: Biochemical analysis of mutations in palmitoyl-protein thioesterase causing infantile and late-onset forms of neuronal ceroid lipofuscinosis. Hum. Mol. Genet. ( 2001 ) 10 (13): 1431-1439 (Pubitemid 32640672)
47. LIN L, SOHAR I, LACKLAND H, LOBEL P: The human CLN2 protein/tripeptidyl- peptidase I is a serine protease that autoactivates at acidic pH. J. Biol. Chem. ( 2001 ) 276 (3): 2249-2255 (Pubitemid 32109709)
48. VENESELLI E, BIANCHERI R, BUONI S, FOIS A: Clinical and EEG fi ndings in 18 cases of late infantile neuronal ceroid lipofuscinosis. Brain Dev. ( 2001 ) 23 (5): 306-311 (Pubitemid 32739216)
49. AUTTI T, JOENSUU R, ABERG L: Decreased T2 signal in the thalami may be a sign of lysosomal storage disease. Neuroradiology ( 2007 ) 49 (7): 571-578 (Pubitemid 47029052)
50. SOHAR I, SLEAT DE, JADOT M, LOBEL P: Biochemical characterization of a lysosomal protease defi cient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models. J. Neurochem. ( 1999 ) 73 (2): 700-711 (Pubitemid 29339844)
51. BERRY-KRAVIS E, SLEAT DE, SOHAR I et al. : Prenatal testing for late infantile neuronal ceroid lipofuscinosis. Ann. Neurol. ( 2000 ) 47 (2): 254-257 (Pubitemid 30078576)
52. VENESELLI E, BIANCHERI R, PERRONE MV, BUONI S, FOIS A: Neuronal ceroid lipofuscinoses: clinical and EEG fi ndings in a large study of Italian cases. Neurol. Sci. ( 2000 ) 21 (3 Suppl.): S75-S81
53. PHILLIPS SN, BENEDICT JW, WEIMER JM, PEARCE DA: CLN3, the protein associated with Batten disease: structure, function and localization. J. Neurosci. Res. ( 2005 ) 79 (5): 573-583 (Pubitemid 40476436)
54. PEARCE DA, SHERMAN F: BTN1, a yeast gene corresponding to the human gene responsible for Batten's disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase. Yeast ( 1997 ) 13 (8): 691-697 (Pubitemid 27287849)
55. PEARCE DA, SHERMAN F: A yeast model for the study of Batten disease. Proc. Natl. Acad. Sci. USA ( 1998 ) 95 (12): 6915-6918 (Pubitemid 28278081)
56. PEARCE DA, NOSEL SA, SHERMAN F: Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p. Mol. Genet. Metab. ( 1999 ) 66 (4): 320-323 (Pubitemid 29390193)
57. PEARCE DA, FEREA T, NOSEL SA, DAS B, SHERMAN F: Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat. Genet. ( 1999 ) 22 (1): 55-58 (Pubitemid 29214804)
58. GOLABEK AA, KIDA E, WALUS M et al. : CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid- ǎ protein precursor and cathepsin D in human cells. Mol. Genet. Metab. ( 2000 ) 70 (3): 203-213 (Pubitemid 30640773)
59. PADILLA-LOPEZ S, PEARCE DA: Saccharomyces cerevisiae lacking Btn1p modulate vacuolar ATPase activity to regulate pH imbalance in the vacuole. J. Biol. Chem. ( 2006 ) 281 (15): 10273-10280 (Pubitemid 43864565)
60. VITIELLO SP, WOLFE DM, PEARCE DA: Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells. Hum. Mol. Genet. ( 2007 ) 16 (9): 1007-1016 (Pubitemid 47062723)
61. RAMIREZ-MONTEALEGRE D, PEARCE DA: Defective lysosomal arginine transport in juvenile Batten disease. Hum. Mol. Genet. ( 2005 ) 14 (23): 3759-3773 (Pubitemid 41754674)
62. KIM Y, RAMIREZ-MONTEALEGRE D, PEARCE DA: A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease. Proc. Natl. Acad. Sci. USA ( 2003 ) 100 (26): 15458-15462 (Pubitemid 38021011)
63. OSORIO NS, CARVALHO A, ALMEIDA AJ et al. : Nitric oxide signaling is disrupted in the yeast model for Batten disease. Mol. Biol. Cell ( 2007 ) 18 (7): 2755-2767 (Pubitemid 47025740)
64. HOBERT JA, DAWSON G: A novel role of the Batten disease gene CLN 3 : association with BMP synthesis. Biochem. Biophys. Res. Commun. ( 2007 ) 358 (1): 111-116 (Pubitemid 46719088)
65. LUIRO K, YLIANNALA K, AHTIAINEN L et al. : Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum. Mol. Genet. ( 2004 ) 13 (23): 3017-3027 (Pubitemid 39585234)
66. PURANAM K, QIAN WH, NIKBAKHT K et al. : Upregulation of Bcl-2 and elevation of ceramide in Batten disease. Neuropediatrics ( 1997 ) 28 (1): 37-41 (Pubitemid 27283156)
67. NARAYAN SB, RAKHEJA D, PASTOR JV et al. : Over-expression of CLN3P, the Batten disease protein, inhibits PANDER-induced apoptosis in neuroblastoma cells: further evidence that CLN3P has anti-apoptotic properties. Mol. Genet. Metab. ( 2006 ) 88 (2): 178-183
68. CAO Y, ESPINOLA JA, FOSSALE E et al. : Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis. J. Biol. Chem. ( 2006 ) 281 (29): 20483-20493 (Pubitemid 44065821)
69. LAURONEN L, MUNROE PB, JARVELA I et al. : Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis. Neurology ( 1999 ) 52 (2): 360-365 (Pubitemid 29059065)
70. EKSANDH LB, PONJAVIC VB, MUNROE PB et al. : Full-fi eld ERG in patients with Batten/Spielmeyer-Vogt disease caused by mutations in the CLN3 gene. Ophthalmic Genet. ( 2000 ) 21 (2): 69-77 (Pubitemid 30623585)
71. LARSEN A, SAINIO K, ABERG L, SANTAVUORI P: Electroencephalography in juvenile neuronal ceroid lipofuscinosis: visual and quantitative analysis. Eur. J. Paediatr. Neurol. ( 2001 ) 5 (Suppl. A): 179-183 (Pubitemid 32677135)
72. AUTTI T, RAININKO R, SANTAVUORI P et al. : MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type. Neuroradiology ( 1997 ) 39 (5): 371-377 (Pubitemid 27216174)
73. NARDOCCI N, VERGA ML, BINELLI S et al. : Neuronal ceroid-lipofuscinosis: a clinical and morphological study of 19 patients. Am. J. Med. Genet. ( 1995 ) 57 (2): 137-141
74. AUTTI T, RAININKO R, VANHANEN SL, SANTAVUORI P: MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis. Neuroradiology ( 1996 ) 38 (5): 476-482 (Pubitemid 26229849)
75. ROTHBERG PG, RAMIREZ-MONTEALEGRE D, FRAZIER SD, PEARCE DA: Homogeneous polymerase chain reaction nucleobase quenching assay to detect the 1-kbp deletion in CLN3 that causes Batten disease. J. Mol. Diagn. ( 2004 ) 6 (3): 260-263 (Pubitemid 39136655)
76. BERKOVIC SF, ANDERMANN F, ANDERMANN E, CARPENTER S, WOLFE L: Kufs disease: clinical features and forms. Am. J. Med. Genet. Suppl. ( 1988 ) 5 : 105-109
77. NIJSSEN PC, CEUTERICK C, VAN DIGGELEN OP et al. : Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 defi ciency. Brain Pathol. ( 2003 ) 13 (4): 574-581 (Pubitemid 37420700)
78. JOSEPHSON SA, SCHMIDT RE, MILLSAP P, MCMANUS DQ, MORRIS JC: Autosomal dominant Kufs' disease: a cause of early onset dementia. J. Neurol. Sci. ( 2001 ) 188 (1-2): 51-60 (Pubitemid 32727873)
79. DONNET A, HABIB M, PELLISSIER JF et al. : Kufs' disease presenting as progressive dementia with late-onset generalized seizures: a clinicopathological and electrophysiological study. Epilepsia ( 1992 ) 33 (1): 65-74
80. BESSA C, TEIXEIRA CA, MANGAS M et al. : Two novel CLN5 mutations in a Portuguese patient with vLINCL: insights into molecular mechanisms of CLN5 defi ciency. Mol. Genet. Metab. ( 2006 ) 89 (3): 245-253 (Pubitemid 44442986)
81. PINEDA-TRUJILLO N, CORNEJO W, CARRIZOSA J et al. : A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset. Neurology ( 2005 ) 64 (4): 740-742 (Pubitemid 40261913)
82. HOLMBERG V, LAURONEN L, AUTTI T et al. : Phenotype-genotype correlation in eight patients with Finnish variant late infantile NCL (CLN5). Neurology ( 2000 ) 55 (4): 579-581 (Pubitemid 30647262)
83. SANTAVUORI P, RAPOLA J, NUUTILA A et al. : The spectrum of Jansky-Bielschowsky disease. Neuropediatrics ( 1991 ) 22 (2): 92-96
84. AUTTI T, RAININKO R, LAUNES J, NUUTILA A, SANTAVUORI P: Jansky-Bielschowsky variant disease: CT, MRI, and SPECT fi ndings. Pediatr. Neurol. ( 1992 ) 8 (2): 121-126
85. SIINTOLA E, TOPCU M, KOHLSCHUTTER A et al. : Two novel CLN6 mutations in variant late-infantile neuronal ceroid lipofuscinosis patients of Turkish origin. Clin. Genet. ( 2005 ) 68 (2): 167-173 (Pubitemid 40990629)
86. TEIXEIRA CA, ESPINOLA J, HUO L et al. : Novel mutations in the CLN6 gene causing a variant late infantile neuronal ceroid lipofuscinosis. Hum. Mutat. ( 2003 ) 21 (5): 502-508 (Pubitemid 36529547)
87. ZHONG N, MOROZIEWICZ DN, JU W et al. : Heterogeneity of late-infantile neuronal ceroid lipofuscinosis. Genet. Med. ( 2000 ) 2 (6): 312-318 (Pubitemid 32046705)
88. LAKE BD, CAVANAGH NP: Early-juvenile Batten's disease - a recognisable sub-group distinct from other forms of Batten's disease. Analysis of 5 patients. J. Neurol. Sci. ( 1978 ) 36 (2): 265-271 (Pubitemid 8301736)
89. TYYNELA J, SUOPANKI J, SANTAVUORI P, BAUMANN M, HALTIA M: Variant late infantile neuronal ceroid-lipofuscinosis: pathology and biochemistry. J. Neuropathol. Exp. Neurol. ( 1997 ) 56 (4): 369-375 (Pubitemid 27465019)
90. RANTA S, LEHESJOKI AE, DE FATIMA BONALDO M et al. : High-resolution mapping and transcript identifi cation at the progressive epilepsy with mental retardation locus on chromosome 8p. Genome Res. ( 1997 ) 7 (9): 887-896 (Pubitemid 27445375)
91. HERVA R, TYYNELA J, HIRVASNIEMI A, SYRJAKALLIO-YLITALO M, HALTIA M: Northern epilepsy: a novel form of neuronal ceroid-lipofuscinosis. Brain Pathol. ( 2000 ) 10 (2): 215-222 (Pubitemid 30181090)
92. CANNELLI N, CASSANDRINI D, BERTINI E et al. : Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: another genetic hit in the Mediterranean. Neurogenetics ( 2006 ) 7 (2): 111-117
93. RANTA S, TOPCU M, TEGELBERG S et al. : Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum. Mutat. ( 2004 ) 23 (4): 300-305 (Pubitemid 38461511)
94. HIRVASNIEMI A, LANG H, LEHESJOKI AE, LEISTI J: Northern epilepsy syndrome: an inherited childhood onset epilepsy with associated mental deterioration. J. Med. Genet. ( 1994 ) 31 (3): 177-182 (Pubitemid 24102194)
95. KOHAN R, DE HALAC IN, TAPIA ANZOLINI V et al. : Palmitoyl protein thioesterase1 (PPT1) and tripeptidyl peptidase-I (TPP-I) are expressed in the human saliva. A reliable and non-invasive source for the diagnosis of infantile (CLN1) and late infantile (CLN2) neuronal ceroid lipofuscinoses. Clin. Biochem. ( 2005 ) 38 (5): 492-494
96. CAMP LA HS: Purifi cation and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. J. Biol. Chem. ( 1993 ) 268 (30): 22566-22574
97. CHO S DG: Enzymatic and molecular biological analysis of palmitoyl-protein thioesterase defi ciency in infantile neuronal ceroid lipofuscinosis. J. Neurochem. ( 1998 ) 71 : 323-329
98. MANIATIS N, COLLINS A, GIBSON J et al. : Positional cloning by linkage disequilibrium. Am. J. Hum. Genet. ( 2004 ) 74 (5): 846-855 (Pubitemid 38568959)
99. MORTON NE: Linkage disequilibrium maps and association mapping. J. Clin. Invest. ( 2005 ) 115 (6): 1425-1430 (Pubitemid 40814646)
100. LANDER ES, BOTSTEIN D: Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science ( 1987 ) 236 (4808): 1567-1570 (Pubitemid 17087948)
101. CROCKETT AO, WITTWER CT: Fluorescein-labeled oligonucleotides for real-time pcr: using the inherent quenching of deoxyguanosine nucleotides. Anal. Biochem. ( 2001 ) 290 (1): 89-97 (Pubitemid 32182273)
102. ANDERSON GW, SMITH VV, BROOKE I, MALONE M, SEBIRE NJ: Diagnosis of neuronal ceroid lipofuscinosis (Batten disease) by electron microscopy in peripheral blood specimens. Ultrastruct. Pathol. ( 2006 ) 30 (5): 373-378 (Pubitemid 44721671)
103. STRIANO P, SPECCHIO N, BIANCHERI R et al. : Clinical and electrophysiological features of epilepsy in Italian patients with CLN8 mutations. Epilepsy Behav. ( 2007 ) 10 (1): 187-191 (Pubitemid 46132172)
104. POET M, KORNAK U, SCHWEIZER M et al. : Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6. Proc. Natl. Acad. Sci. USA ( 2006 ) 103 (37): 13854-13859 (Pubitemid 44413997)
105. VAN DIGGELEN OP, THOBOIS S, TILIKETE C et al. : Adult neuronal ceroid lipofuscinosis with palmitoyl-protein thioesterase defi ciency: fi rst adult-onset patients of a childhood disease. Ann. Neurol. ( 2001 ) 50 (2): 269-272 (Pubitemid 32738156)
106. RAMADAN H, AL-DIN AS, ISMAIL A et al. : Adult neuronal ceroid lipofuscinosis caused by defi ciency in palmitoyl protein thioesterase 1. Neurology ( 2007 ) 68 (5): 387-388 (Pubitemid 46188247)
107. DAS AK, BECERRA CH, YI W et al. : Molecular genetics of palmitoyl-protein thioesterase defi ciency in the US. J. Clin. Invest. ( 1998 ) 102 (2): 361-370 (Pubitemid 28335195)
108. WISNIEWSKI KE, KACZMARSKI A, KIDA E et al. : Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol. Genet. Metab. ( 1999 ) 66 (4): 248-252 (Pubitemid 29390182)
109. http://www.ucl.ac.uk/ncl/ NCL Resource: a gateway for Batten disease
110. http://www.ncbi.nlm.nih.gov/sites/ entrez?db=snp Entrez single nucleotide polymorphism database.
111. http://dbb.urmc.rochester.edu/labs/pearce/ bddcrc/index.htm University of Rochester Medical Center Batten Disease Diagnostic and Clinical Research Center.